REFERENCES
1. Pavlova EL, Simeonova LS, Gegova GA. Combined efficacy of oseltamivir, isoprinosine and ellagic acid in influenza A(H3N2)-infected mice. Biomed Pharmacother. 2018;98:29-35.
2. Park SW, Kwon MJ, Yoo JY, Choi H-J, Ahn Y-J. Antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa leaves toward human rhinoviruses. BMC Complement Altern Med. 2014 May 26;14:171.
3. Cui Q, Du R, Anantpadma M, Schafer A, Hou L, Tian J, et al. Identification of ellagic acid from plant Rhodiola rosea L. as an anti-Ebola virus entry inhibitor. Viruses. 2018 27;10(4). pii: E152.
4. Promsong A, Chuenchitra T, Saipin K, Tewtrakul S, Panichayupakaranant P, Satthakarn S,et al. Ellagic acid inhibits HIV-1 infection in vitro: Potential role as a novel microbicide. Oral Dis. 2018;24(1-2):249-252.
5. Vilhelmova-Ilieva N, Jacquet R, Deffieux D, Pouységu L, Sylla T, Chassaing S. Anti-Herpes Simplex Virus Type 1 Activity of Specially Selected Groups of Tannins. Drug Res (Stuttg). 2019 Jul;69(7):374-373.
6. Pavlova EL, Zografov NN, Simeonova LS. Comparative study on the antioxidant capacities of synthetic influenza inhibitors and ellagic acid in model systems. Biomed Pharmacother. 2016 Oct;83:755-762.
7. Aslan A, Hussein YT, Gok O, Beyaz S, Erman O, Baspinar S. Ellagic acid ameliorates lung damage in rats via modulating antioxidant activities, inhibitory effects on inflammatory mediators and apoptosis-inducing activities. Environ Sci Pollut Res Int. 2020 Mar;27(7):7526-7537.
8. Cornélio Favarin D, Martins Teixeira M, Lemos de Andrade E, de Freitas Alves C, Lazo Chica JE, Artério Sorgi C, et al. Anti-inflammatory effects of ellagic acid on acute lung injury induced by acid in mice. Mediators Inflamm. 2013;2013:164202.